Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.78
+0.20 (3.04%)
At close: Mar 27, 2026

HKG:0512 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
23,74227,48916,80914,39416,22522,930
Market Cap Growth
28.65%63.54%16.78%-11.29%-29.24%-6.11%
Enterprise Value
25,72929,89918,29916,58118,12422,786
Last Close Price
6.787.854.593.714.045.53
PE Ratio
19.1322.156.817.667.809.54
Forward PE
14.1311.948.117.317.909.61
PS Ratio
1.932.241.441.371.702.67
PB Ratio
1.381.601.020.941.141.71
P/TBV Ratio
1.972.281.281.121.341.95
P/FCF Ratio
--12.527.4313.3414.95
P/OCF Ratio
--8.865.948.8111.43
EV/Sales Ratio
2.092.431.571.581.902.65
EV/EBITDA Ratio
11.1913.456.845.165.839.14
EV/EBIT Ratio
13.9416.908.245.806.6010.50
EV/FCF Ratio
--13.638.5614.9014.85
Debt / Equity Ratio
0.280.280.270.220.320.27
Debt / EBITDA Ratio
2.132.131.631.051.421.46
Debt / FCF Ratio
--3.311.763.682.38
Net Debt / Equity Ratio
0.110.110.040.010.080.01
Net Debt / EBITDA Ratio
0.820.820.270.040.370.06
Net Debt / FCF Ratio
--0.530.070.940.10
Asset Turnover
0.470.470.490.470.440.45
Inventory Turnover
3.863.863.562.942.943.23
Quick Ratio
0.930.931.010.980.861.00
Current Ratio
1.141.141.221.221.071.22
Return on Equity (ROE)
7.38%7.38%15.51%12.86%15.18%19.41%
Return on Assets (ROA)
4.24%4.24%5.84%7.96%7.91%7.13%
Return on Invested Capital (ROIC)
7.75%8.13%11.77%15.04%15.83%15.13%
Return on Capital Employed (ROCE)
8.90%8.90%12.10%17.00%17.30%14.00%
Earnings Yield
5.23%4.51%14.69%13.06%12.82%10.48%
FCF Yield
--7.99%13.46%7.50%6.69%
Dividend Yield
2.49%2.15%5.67%7.01%3.46%1.99%
Payout Ratio
--36.88%26.43%18.78%16.25%
Buyback Yield / Dilution
--0.17%0.97%0.16%-2.98%
Total Shareholder Return
3.83%2.15%5.83%7.99%3.62%-1.00%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.